Pérez-Ruixo, Juan José <br/><br/>
Pharmacokinetics and pharmacodynamics of the erythropoietin Mimetibody construct CNTO 528 in healthy subjects.  [electronic resource] 

 -  Clinical pharmacokinetics  2009 
 - 601-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-1926 
<br/><br/><label>Standard No.: </label>10.2165/11317190-000000000-00000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anemia--drug therapy<br/>Antibodies, Monoclonal--administration & dosage<br/>Computer Simulation<br/>Drug Dosage Calculations<br/>Erythrocyte Count<br/>Erythropoietin<br/>Half-Life<br/>Hemoglobins--analysis<br/>Humans<br/>Immunoglobulin Heavy Chains<br/>Male<br/>Middle Aged<br/>Models, Biological<br/>Peptides, Cyclic<br/>Receptors, Erythropoietin--agonists<br/>Recombinant Fusion Proteins--pharmacokinetics<br/>Reticulocyte Count<br/>Reticulocytes--drug effects<br/>Single-Blind Method<br/>Young Adult